GEMMA, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 3.480
EU - Europa 1.644
AS - Asia 1.643
SA - Sud America 262
AF - Africa 57
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.097
Nazione #
US - Stati Uniti d'America 3.247
SG - Singapore 607
CN - Cina 365
IT - Italia 360
DE - Germania 260
RU - Federazione Russa 228
SE - Svezia 218
CA - Canada 210
BR - Brasile 200
VN - Vietnam 195
HK - Hong Kong 188
IE - Irlanda 150
UA - Ucraina 100
GB - Regno Unito 86
IN - India 86
FR - Francia 68
DK - Danimarca 41
FI - Finlandia 33
BD - Bangladesh 28
TR - Turchia 25
IQ - Iraq 22
NL - Olanda 22
AR - Argentina 21
MX - Messico 18
ZA - Sudafrica 18
BE - Belgio 17
KR - Corea 16
ES - Italia 15
SA - Arabia Saudita 15
ID - Indonesia 13
EC - Ecuador 12
JP - Giappone 12
CO - Colombia 11
PK - Pakistan 10
PL - Polonia 10
PH - Filippine 9
VE - Venezuela 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
EG - Egitto 6
UZ - Uzbekistan 6
AT - Austria 5
CL - Cile 5
ET - Etiopia 5
MY - Malesia 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
IR - Iran 4
MA - Marocco 4
NP - Nepal 4
TW - Taiwan 4
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
EU - Europa 3
KE - Kenya 3
OM - Oman 3
TH - Thailandia 3
BH - Bahrain 2
BO - Bolivia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
ZM - Zambia 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BF - Burkina Faso 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
KG - Kirghizistan 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
NC - Nuova Caledonia 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 7.094
Città #
Singapore 337
Ann Arbor 325
Ashburn 298
Woodbridge 279
Fairfield 207
San Jose 187
Hong Kong 185
Chandler 179
Toronto 160
Houston 151
Dublin 143
Frankfurt am Main 130
Wilmington 120
Milan 99
Jacksonville 91
New York 88
Dearborn 75
Cambridge 74
Seattle 70
Dallas 65
The Dalles 60
Los Angeles 57
Ho Chi Minh City 55
Santa Clara 54
Princeton 53
Beijing 52
Hanoi 44
Chicago 43
Rome 39
Shanghai 33
Nanjing 32
Buffalo 29
Altamura 27
Lauterbourg 25
Lawrence 24
Council Bluffs 21
Orem 21
Columbus 17
Lachine 17
Boston 15
Moscow 15
Helsinki 14
Johannesburg 14
Fremont 13
San Diego 13
São Paulo 13
Guangzhou 12
Brussels 11
Da Nang 11
Munich 11
Tianjin 11
Dong Ket 10
Haiphong 10
Shenyang 10
London 9
Seoul 9
Tokyo 9
Hefei 8
Jinan 8
Manchester 8
Mountain View 8
Ottawa 8
Valencia 8
Washington 8
Amsterdam 7
Chennai 7
Denver 7
Nanchang 7
Rio de Janeiro 7
Riyadh 7
Warsaw 7
Andover 6
Boardman 6
Brooklyn 6
Hangzhou 6
Jiaxing 6
Lissone 6
Mexico City 6
Montreal 6
Paris 6
Phoenix 6
Tashkent 6
Baghdad 5
Brasília 5
Cairo 5
Changsha 5
Charlotte 5
Delhi 5
Edmonton 5
Hebei 5
Jakarta 5
Medellín 5
Mumbai 5
Nuremberg 5
Nürnberg 5
Salvador 5
San Francisco 5
Valmadrera 5
Addis Ababa 4
Baku 4
Totale 4.435
Nome #
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 459
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 388
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 364
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 323
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 316
The impact of liver disease on the health-related quality of life 306
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 305
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 304
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 292
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 291
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 289
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 287
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 283
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 282
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 275
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 273
Health Related Quality of Life in the Major Liver Conditions 270
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 269
Feasibility of standard mechanical ventilation with low FiO2 and small endotracheal tubes during laser microlaryngeal surgery 252
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 242
Distribution of the cortico-spinal fibres in the cervical and lumbar enlargements of the rat spinal cord 238
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 237
MortalitY in caRdIAc surgery (MYRIAD): A randomizeD controlled trial of volatile anesthetics. Rationale and design 230
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 215
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 165
Continuous use of neuromuscular relaxants in the management of head injured patients 151
Totale 7.306
Categoria #
all - tutte 22.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022319 17 28 33 46 3 33 16 32 15 18 17 61
2022/2023685 67 257 46 58 30 89 10 49 37 3 32 7
2023/2024443 17 14 8 38 41 133 88 15 38 5 4 42
2024/20251.002 66 99 96 31 82 31 50 33 145 161 79 129
2025/20262.532 311 104 181 196 274 105 338 98 218 256 282 169
2026/20278 8 0 0 0 0 0 0 0 0 0 0 0
Totale 7.306